TMA
The company announced the launch of the new products in the US and Europe as part of a product portfolio it has named Panther Scalable Solutions.
The upgrades include a method to connect Panther systems to create a higher-throughput system that can be configured to different footprints.
Roka Bio Revenues Grow 7 Percent in Q2
While instrument placements in the quarter increased to 41 from 36 a year ago, the firm missed the consensus analysts' estimate on the top and bottom lines.
DiagnoCure Prods Commercial Partner Hologic to Step Up Marketing for PCA3 Test or Give it Back
Premium
Unhappy with the sales of its urine-based molecular test for the prostate cancer biomarker PCA3, Canadian cancer diagnostics firm DiagnoCure is urging Hologic, the test's commercial conduit, to either step up commercialization efforts or relinquish rights to the test back to Diag
Hologic said this week that fiscal first-quarter clinical diagnostics revenues from Gen-Probe, acquired last summer, were up 9 percent over the comparable period last year, but that blood screening revenues contributed by Gen-Probe declined slightly year over year.
Jan 19, 2012
Jan 12, 2012
Jul 28, 2011
Jan 20, 2011
Dec 2, 2010
Jan 28, 2010